Tag: The Food and Drug Administration

Live Q&A: Judge Refuses FDA Request, Gives 8 Months for Pfizer Data; Trump Social Network Nears

January 9, 2022
administrationcongressCrossroadsEpochTVFDALive VideospandemicPfizer vaccineThe Food and Drug Administrationthe Supreme Courtvaccine mandatesVideo
0 Comment

The Food and Drug Administration’s request for 75 years before it fully releases information on how it approved the Pfizer COVID-19 vaccine has been shot down by a federal judge. The FDA now has just over 8 months to provide these documents for public review. U.S. District Judge Mark Pittman ordered the FDA to produce…

Read More

Live Q&A: FDA Approves New COVID-19 Treatment Pills; WHO Warns Policies Could Cause Virus Mutations

December 23, 2021
CrossroadsEpochTVLive VideosThe Food and Drug AdministrationVideoWorld Health Organization
0 Comment

The Food and Drug Administration (FDA) authorized new medications to treat COVID-19, with emergency authorizations for treatment pills from both Pfizer and Merck. The federal government also announced it will purchase 10 million courses of the Pfizer drug. The Pfizer one is called Paxlovid and is taken twice per day for five days alongside a…

Read More

Live Q&A: FDA Wants 75 Years to Release Pfizer Data; China’s Economy Braces as Evergrande Defaults

December 9, 2021
BioNTechCrossroadsEpochTVFDALive VideosPfizerThe Food and Drug AdministrationVideo
0 Comment

The Food and Drug Administration (FDA) wants 75 years before it fully makes public its data on the Pfizer and BioNTech vaccines. And in other news, China’s Evergrande has defaulted, and the world is now bracing for the potential economic impact. In this live Q&A with Crossroads host Joshua Philipp, we’ll discuss these stories and…

Read More

FDA Approves Biogen Alzheimer’s Drug

June 7, 2021
Alzheimer’sbiogenThe Food and Drug AdministrationUSUS News
0 Comment

Government health official on Monday approved Biogen’s aducanumab as the first treatment to attack a likely cause of Alzheimer’s disease, sending its shares soaring, despite controversy over whether the clinical evidence proves the drug works. Biogen said it has priced the drug, to be sold as Aduhelm, at $56,000 per year. Its shares jumped nearly…

Read More